FIBROGEN INC·4

Jan 10, 6:16 PM ET

DeLucia David 4

4 · FIBROGEN INC · Filed Jan 10, 2025

Insider Transaction Report

Form 4
Period: 2025-01-09
DeLucia David
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-09+525,000525,000 total
    Exercise: $0.65Exp: 2035-01-08Common Stock (525,000 underlying)
Footnotes (1)
  • [F1]The option vests in equal amount quarterly over 4 years measured from 1/9/2025.

Documents

1 file
  • 4
    form4-01102025_110123.xmlPrimary